Hacker News Reader

Comment by blindriver | Hacker News Reader

Pharma companies aren’t incentivized to cure HIV. Gilead found a cure for Hepatitis C but instead of being praised for it, it was derided by Wall Street because the limited financial value. I certainly hope a more honorable company will find a cure instead of a monthly treatment like Ozempic, which is a Wall Street darling because it’s expensive and monthly.

View on HN

Human Beings are incentivized to cure HIV. Real people are experiencing real pain and problem to the tune of millions of persons a year. It is among the most stigmatized long-term illnesses on the planet.

Maybe BigCo Evil Pharma isn't "incentivized" to cure HIV; but hundreds of universities including those outside the United States, are. The US does not hold a monopoly on medical advancement.

HIV is *hard* to cure. That's why it's not been cured yet.

> Human Beings are incentivized to cure

i'm not so sure, insulin for diabetes is a solved problem yet it's costs hundreds of $ all because scumy of pharma corps(looking at you Eli Lily) keep renewing the patent using legal loopholes.

...in the US.

Gilead charges $85k for Harvoni. There's also alternative drugs from different manufacturers because there still lots of money to made. Treatments you're constrained by the duration of the patent thats need to be filed before trials. You're looking at a max of 14 years. Ozempic runs out 2032 but there are already alternative drugs.

Watch Excision Biotheraputics. I almost guarantee it’ll get bought and killed.

Thankfully these folks are Australian and have socialized medicine where they're incentivized to fix the underlying condition instead of treating the symptoms

> a more honorable company

This is sad…

Reply on news.ycombinator.com